Cargando…
Somatostatin Receptor Type 2 Antagonism Improves Glucagon and Corticosterone Counterregulatory Responses to Hypoglycemia in Streptozotocin-Induced Diabetic Rats
Diminished responsiveness to hypoglycemia contributes to defective counterregulation in diabetes. Pancreatic and/or circulating somatostatin are elevated in diabetes, which may inhibit counterregulatory hormone release during hypoglycemia. Thus, a selective somatostatin receptor type 2 antagonist (S...
Autores principales: | Yue, Jessica T.Y., Burdett, Elena, Coy, David H., Giacca, Adria, Efendic, Suad, Vranic, Mladen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3237655/ https://www.ncbi.nlm.nih.gov/pubmed/22106159 http://dx.doi.org/10.2337/db11-0690 |
Ejemplares similares
-
Amelioration of Hypoglycemia Via Somatostatin Receptor Type 2 Antagonism in Recurrently Hypoglycemic Diabetic Rats
por: Yue, Jessica T.Y., et al.
Publicado: (2013) -
The Medial Amygdalar Nucleus: A Novel Glucose-Sensing Region That Modulates the Counterregulatory Response to Hypoglycemia
por: Zhou, Ligang, et al.
Publicado: (2010) -
Amplified Hormonal Counterregulatory Responses to Hypoglycemia in Rats After Systemic Delivery of a SUR-1–Selective K(+) Channel Opener?
por: Fan, Xiaoning, et al.
Publicado: (2008) -
Perifornical Hypothalamic Orexin and Serotonin Modulate the Counterregulatory Response to Hypoglycemic and Glucoprivic Stimuli
por: Otlivanchik, Oleg, et al.
Publicado: (2015) -
Effects of Antecedent GABA A Receptor Activation on Counterregulatory Responses to Exercise in Healthy Man
por: Hedrington, Maka S., et al.
Publicado: (2015)